|
Device passed the functional test, including the displacement test, rewind, basic occlusion test, occlusion test, prime or a33 test, excessive no delivery test and delivery accuracy test at 0.08715 inches.The stop (idle) current and run current measurement tests are within specification.Device also passed self test, off no power alarm test and a21 error test.The no delivery alarm functions properly during the basic occlusion test and occlusion test.No unexpected no delivery alarm noted during testing.The test battery was removed and reinserted with no failed battery test alarm noted.Device was programmed and monitored for 3 days.No frozen screen or rainbow display anomaly noted.No drive or /motor anomaly noted.The motor was tested outside of the device and passed.Device recognized the water filled reservoir that was installed in the reservoir compartment.Device was programmed with a 2.0 unit fill cannula delivery.Then the device delivered the 2.0 units properly with water exiting the infusion set.No prime or fill anomaly noted.No missing piece or part noted on the device.Device had cracked battery tube threads, scratched case and scratched reservoir tube window.The test p-cap and reservoir does lock in place in the reservoir compartment.This mdr related to the puerto rico manufacturing site has been assigned a medwatch number from the medtronic minimed northridge site, per variance 5.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|